National Cancer Institute; Notice of Closed Meetings, 54989 [2014-21854]

Download as PDF Federal Register / Vol. 79, No. 178 / Monday, September 15, 2014 / Notices phase images of lightly absorbing samples. Potential Commercial Applications: • Clinical diagnostics • Research tools Competitive Advantages: • More sensitivity • Easier to fabricate images Development Stage: • In vitro data available • In vivo data available (animal) Inventor: Han Wen (NHLBI) Publications: 1. Wen H. Boosting phase contrast with two-arm interferometers using submicron period gratings. Presentation, The Royal Society, London scientific discussion meeting: Taking x-ray phase contrast imaging into mainstream applications, February 11, 2013, London, UK. 2. Momose A, Fukuda J. Phasecontrast radiographs of nonstained rat cerebellar specimen. Med Phys. 1995 Apr;22(4):375–9. [PMID 7609717]. 3. Clauser JF. Ultrahigh resolution interferometric x-ray imaging. U.S. Patent No. 5,812,629 issued 22 Sep 1998. [https://patft1.uspto.gov/netacgi/ nph-Parser?patentnumber=5812629]. Intellectual Property: HHS Reference No. E–114–2013/0—U.S. Provisional Application No. 61/877,228 filed 12 Sep 2013. Licensing Contact: John Stansberry, Ph.D.; 301–435–5236; stansbej@ mail.nih.gov. Collaborative Research Opportunity: The National Heart, Lung, and Blood Institute is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate or commercialize the technology. For collaboration opportunities, please contact Dr. Denise Crooks at crooksd@ mail.nih.gov. Dated: September 9, 2014. Richard U. Rodriguez, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. 2014–21856 Filed 9–12–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES tkelley on DSK3SPTVN1PROD with NOTICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. VerDate Mar<15>2010 17:10 Sep 12, 2014 Jkt 232001 The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c) (4) and 552b(c) (6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; R01 Review. Date: October 16, 2014. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 2W030, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Majed M. Hamawy, Ph.D., MBA, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W120, Bethesda, MD 20892–9750, 240–276– 6457, mh101v@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts. Date: October 21–22, 2014. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W030–Oct 21, 5E030 Oct 22, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division Of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W244, Rockville, MD 20850, 240– 276–6373, bielatk@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Revisions Early Stage Informatics Technologies, Revisions Early Stage Informatics Technologies, Advanced Stage Informatics Technologies. Date: November 4–5, 2014. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7E030–Nov 4, 5E030–Nov 5 Rockville, MD 20850, (Telephone Conference Call). Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch. Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, 7W244, Rockville, MD 20850, 240– 276–6373, bielatk@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Imaging and Biomarkers for Early Cancer Detection. PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 54989 Date: November 14, 2014. Time: 11:00 a.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 1E030, Rockville, MD 20892–9750, (Telephone Conference Call). Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W244, Rockville, MD 20850, 240– 276–66373, bielatk@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS). Dated: September 9, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–21854 Filed 9–12–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Endocrinology, Metabolism, Nutrition and Reproductive Sciences Integrated Review Group, Integrative Nutrition and Metabolic Processes Study Section. Date: October 9, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\15SEN1.SGM 15SEN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 79, Number 178 (Monday, September 15, 2014)]
[Notices]
[Page 54989]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21854]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c) (4) and 552b(c) (6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; R01 Review.
    Date: October 16, 2014.
    Time: 2:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2W030, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Majed M. Hamawy, Ph.D., MBA, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W120, Bethesda, MD 20892-9750, 240-276-6457, mh101v@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Core Infrastructure and Methodological Research for Cancer 
Epidemiology Cohorts.
    Date: October 21-22, 2014.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W030-Oct 21, 5E030 Oct 22, Rockville, MD 20850, 
(Telephone Conference Call).
    Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division Of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W244, Rockville, MD 20850, 240-276-6373, 
bielatk@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Revisions Early Stage Informatics Technologies, Revisions 
Early Stage Informatics Technologies, Advanced Stage Informatics 
Technologies.
    Date: November 4-5, 2014.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7E030-Nov 4, 5E030-Nov 5 Rockville, MD 20850, 
(Telephone Conference Call).
    Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch. Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, 7W244, Rockville, MD 20850, 240-276-6373, 
bielatk@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Imaging and Biomarkers for Early Cancer Detection.
    Date: November 14, 2014.
    Time: 11:00 a.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 1E030, Rockville, MD 20892-9750, (Telephone 
Conference Call).
    Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W244, Rockville, MD 20850, 240-276-66373, 
bielatk@mail.nih.gov.
    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS).

    Dated: September 9, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-21854 Filed 9-12-14; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.